| |
 |
|
Class Information
Number: 424/257.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Escherichia (e.g., escherichia coli, etc.)
Description: Subject matter wherein the bacterium is of the genus Escherichia.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6153396 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Nov. 28, 2000 |
| 6149919 |
Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
Nov. 21, 2000 |
| 6121296 |
Transition-state inhibitors for nucleoside hydrolase and transferase reactions |
Sep. 19, 2000 |
| 6096322 |
Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing |
Aug. 1, 2000 |
| 6096321 |
ClpG subunit of CS31A protein capsule containing heterologous peptides |
Aug. 1, 2000 |
| 6083928 |
Skin healing method |
Jul. 4, 2000 |
| 6077516 |
Live vaccine against colibacillosis |
Jun. 20, 2000 |
| 6060067 |
Process for the preparation of tetanus toxoid vaccine |
May. 9, 2000 |
| 6045805 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Apr. 4, 2000 |
| 6040421 |
Escherichia coli O157:H7 epithelial adhesion and vaccine |
Mar. 21, 2000 |
| 6030619 |
Molecular mimetics of meningococcal B epitopes |
Feb. 29, 2000 |
| 6027736 |
Active immunization using a siderophore receptor protein |
Feb. 22, 2000 |
| 6007818 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Dec. 28, 1999 |
| 5980907 |
Vaccines containing bacteria attenuated by mutation of the htrA gene |
Nov. 9, 1999 |
| 5961983 |
Stable pura vectors and uses therefor |
Oct. 5, 1999 |
| 5961985 |
Vaccine and serum for endotoxin associated disease immunization and treatment, detoxified endotoxin, and bacterial mutant |
Oct. 5, 1999 |
| 5951987 |
Polysaccharide vaccine to enhance immunity against brucellosis |
Sep. 14, 1999 |
| 5929109 |
Enhancing and stabilizing agent of the activity of Bifidus factor |
Jul. 27, 1999 |
| 5914114 |
Method of raising antibodies against E. coli of the family CS4-CFA/I |
Jun. 22, 1999 |
| 5908630 |
Swine immunization using live, RTX toxin-secreting organisms |
Jun. 1, 1999 |
| 5906826 |
Method of inducing an immune response in a young animal |
May. 25, 1999 |
| 5888799 |
Recombinant avirulent bacterial antigen delivery system |
Mar. 30, 1999 |
| 5869058 |
Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
Feb. 9, 1999 |
| 5858367 |
Methods for screening for antimicrobials utilizing AarC and compositions thereof |
Jan. 12, 1999 |
| 5855880 |
Avirulent microbes and uses therefor |
Jan. 5, 1999 |
| 5855879 |
Avirulent microbes and uses therefor |
Jan. 5, 1999 |
| 5800981 |
Human cytomegalovirus antigen and its use |
Sep. 1, 1998 |
| 5762943 |
Methods of treating type I hypersensitivity using monophosphoryl lipid A |
Jun. 9, 1998 |
| 5759992 |
Immunotherapeutic agent derived from bacteria and method for its manufacture |
Jun. 2, 1998 |
| 5750115 |
Escherichia coli vaccine |
May. 12, 1998 |
| 5747309 |
Bacterial vaccines using vaccine strains of pathogenic bacteria |
May. 5, 1998 |
| 5641491 |
Escherichia coli strain 364 and use of said strain as a vaccine |
Jun. 24, 1997 |
| 5616328 |
Method of preparing gram-negative bacterial vaccines |
Apr. 1, 1997 |
| 5593679 |
Poultry vaccine against E. coli air sac inflammation and septicaemia |
Jan. 14, 1997 |
| 5538733 |
Method of priming an immune response in a one-day old animal |
Jul. 23, 1996 |
| 5538727 |
Anti-cholesterolemic vaccine |
Jul. 23, 1996 |
| 5538727 |
Anti-cholesterolemic vaccine |
Jul. 23, 1996 |
| 5538733 |
Method of priming an immune response in a one-day old animal |
Jul. 23, 1996 |
| 5527770 |
Immunotherapeutic agent derived from bacteria |
Jun. 18, 1996 |
| 5374423 |
Method of using cytokine receptors on microorganism |
Dec. 20, 1994 |
| 5370872 |
Escherichia coliO-polysaccharide-protein conjugate vaccine |
Dec. 6, 1994 |
| 5270038 |
Tumor necrosis factor receptors on microorganisms |
Dec. 14, 1993 |
| 5208024 |
Vaccine against E. coli septicaemia in poultry |
May. 4, 1993 |
| 5182109 |
Vaccine preparation comprising a bacterial toxin adjuvant |
Jan. 26, 1993 |
| 5137721 |
Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli |
Aug. 11, 1992 |
| 5079165 |
Production of the E. coli LT-B enterotoxin subunit in S. typhi |
Jan. 7, 1992 |
| 5071969 |
Sulphated K5 antigen and sulphated K5 antigen fragments |
Dec. 10, 1991 |
| 5066596 |
Bacterial strains harboring cloned genes controlling Vibrio cholerae O-antigen biosynthesis |
Nov. 19, 1991 |
| 5026543 |
Adjuvant mixture |
Jun. 25, 1991 |
| 4971794 |
Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili |
Nov. 20, 1990 |
|
|
|
